Skip to main content
. 2020 Jun 8;4(11):2516–2522. doi: 10.1182/bloodadvances.2019001409

Table 3.

Duplex US test accuracy in a low- and high-prevalence population

Test result Number of results per 1000 patients tested (95% CI) Number of participants (studies) Quality of the evidence (GRADE)
Prevalence 10%* Prevalence 40%*
True positives 87 (73-95) 349 (292-378) 465 (7) ⨁⨁⨁◯ Moderate§
False negatives 13 (5-27) 51 (22-108)
True negatives 764 (646-833) 509 (431-556) 465 (7) ⨁⨁⨁◯ Moderate§
False positives 136 (67-254) 91 (44-169)
Inconclusive test results Not reported
Complications arising from the diagnostic test Not reported

An interactive summary of findings table is available at: https://gdt.gradepro.org/presentations/#/isof/isof_fb2275e1-b029-4dda-a58b-0e5992c809ac-1590262303875?_k=zs2fxi. Patient or population: Patients with suspected UEDVT. New test: Duplex US. Setting: Inpatient and outpatient. Pooled sensitivity: 0.87 (95% CI, 0.73-0.94). Pooled specificity: 0.85 (95% CI, 0.72-0.93)

*

Data from Constans et al.14

Data from Kleinjan et al.18

Not downgraded for risk of bias, though few studies had unclear information on standard reference test.

§

One study (Haire et al20) had a wide CI for sensitivity and specificity not overlapping with other studies. In consideration of the inconsistency and imprecision, we downgraded by 1 level.